Trials / Completed
CompletedNCT01470638
A Study of Flt3-Ligand Levels in Sjögrens Syndrome
Analyzes of Cerebrospinal Fluid in Autoimmune Systemic Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Göteborg University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.
Detailed description
The study aims to correlate levels of Flt3-ligand in CSF and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.
Conditions
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
- First posted
- 2011-11-11
- Last updated
- 2019-04-24
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01470638. Inclusion in this directory is not an endorsement.